左旋吡喹酮脂质体及吡喹酮脂质体治疗小鼠血吸虫病  被引量:1

Levo-praziquantal Liposome and Praziquantel Liposome Therapy of Schistosomiasis in Mice

在线阅读下载全文

作  者:卓超[1] 王小根[1] 刘约翰[1] 余登高[1] 余瑜[1] 

机构地区:[1]重庆医科大学传染病寄生虫病研究所,重庆630042

出  处:《中国人兽共患病杂志》1997年第3期31-35,共5页Chinese Journal of Zoonoses

摘  要:本研究用逆道相蒸发法制备左旋吡喹酮脂质体和吡喹酮脂质体。左旋吡喹酮脂质低(L-PZQL)和吡喹酮脂质体(PZQL)剂量均为25和50mg/kg/次,吡喹酮(PZQ)剂量为100和200mg/kg/次,以一次灌胃连续两日治疗小鼠血吸虫病。L-PZQL50mg/kg和100mg/kg治疗组减虫率分别为551%和74.5%,PZQL50mg/kg和100mg/kg治疗组减虫率分别为20.9%和55.7%,同剂量的L-PZQL与PZQL组减虫率比较有显著性差异(P<0.01)。PZQ200mg/kg、400mg/kg组减虫率分别为59.2%和79.1%。L-PZQL疗效较PZQ高4倍。形态学观察,化疗后血吸虫成虫皮层受损害,以L-PZQL100mg/kg组和PZQ400mg/kg组尤为明显。肝脏病理学改变提示,脂质体药物组与对照组相比,肝脏嗜酸性由芽肿减少,以慢性虫卵结节居多,虫卵结书直径变小。实验说明,L-PZQL100mg/kg治疗小鼠血吸虫病的疗效类似于PZQ400mg/kg。Levo-praziquantel liposome and praziquantel liposome were prepared by a reverse phase evaporation method. The encapsulated rate was over 98. 21%. Mice infected with schistosome japonica were treated intergastrically with L-PZQL in dose of 25 and 50mg/kg,daily,consecutive 2 days. The worm reduction rates were 55. 1% and 74.5 %,while those of PZQL at same dosage were 20.9% and 55.7%,respectively. There was difference between L-PQZL and PZQL groups (P<0. 01). The rates in PZQ 200mg/kg and 400mg/kg groups were 59.2% and 79.1%,respctively. The efficacy of L-PZQL was higher 4 times than that of PZQ. In morpholoy the worms were shortened and tegument lesions was obvious especially in L-PZQL 100mg/kg and PZQL 400mg/kg groups. In pathological examination the liver from the treated mice were observed that the number of eosinophilic abscess were reduced and its diameter also were lessened,therfore,fibrous granuloma were remarkablely increased in L-PZQL 100mg/kg group.The results suggested that the efficacy of L-PZQL 100mg/kg should be similar to dosage of PZQ 400mg/kg in the treatment of schistosomiasis in mice.

关 键 词:左旋吡喹酮 脂质体 日本血吸虫病 

分 类 号:R532.210.5[医药卫生—内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象